Translational Science In Drug Development: Surrogate Endpoints, Biomarkers, and More
The Duke Margolis Center for Health Policy, in collaboration with the FDA, is convening a virtual two-day workshop May 24-25 from 12pm ET – 4pm ET, titled “Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More.” This workshop will be of key relevance to a wide array of faculty, staff, and students working in […]
